Joseph De Rutte
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$8.3MFederal grants as PI16 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
16 awards · $8.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 1, 2026 | NIH | SBIR Phase II Nanovial Kits for Large-Scale Cell-Cell Interaction Sequencing | $979K | PARTILLION BIOSCIENCE CORPORATION |
| Jul 16, 2026 | NIH | SBIR Phase I Multiplexed analysis of antibody secreting cells for enhanced function first antibody discovery | $307K | PARTILLION BIOSCIENCE CORPORATION |
| Jun 9, 2026 | NIH | SBIR Phase II Scaling function-first antibody discovery leveraging memory B cells | $1.0M | PARTILLION BIOSCIENCE CORPORATION |
| Apr 1, 2025 | NIH | SBIR Phase II Scaling function-first antibody discovery leveraging memory B cells | $1.0M | PARTILLION BIOSCIENCE CORPORATION |
| Sep 1, 2024 | NIH | SBIR Phase II Linking antibody sequences to function at the single-cell level using nanovial technology | $732K | PARTILLION BIOSCIENCE CORPORATION |
| Aug 22, 2024 | NIH | SBIR Phase II Hydrogel microparticle technology for high-throughout screening of chimeric antigen receptor-T cells based on single cell effector function | $742K | PARTILLION BIOSCIENCE CORPORATION |
| Sep 13, 2023 | NIH | SBIR Phase II Linking antibody sequences to function at the single-cell level using nanovial technology | $768K | PARTILLION BIOSCIENCE CORPORATION |
| Sep 6, 2023 | NIH | SBIR Phase II Hydrogel microparticle technology for high-throughout screening of chimeric antigen receptor-T cells based on single cell effector function | $755K | PARTILLION BIOSCIENCE CORPORATION |
| Jul 18, 2023 | NIH | SBIR Phase I Multiplexed analysis of secreted proteins from single-cells using high dynamic range nanovials | $275K | PARTILLION BIOSCIENCE CORPORATION |
| Sep 16, 2021 | NIH | SBIR Phase I High-throughput antibody discovery directly from B cells using nanovial technology | $355K | PARTILLION BIOSCIENCE CORPORATION |
| Sep 1, 2021 | NSF | SBIR Phase I SBIR Phase I: Microparticle reagents for clonal selection of producer cell lines | $256K | PARTILLION BIOSCIENCE CORPORATION |
| Jun 16, 2021 | NSF | SBIR Phase I SBIR Phase I: Microparticle reagents for clonal selection of producer cell lines | $256K | PARTILLION BIOSCIENCE CORPORATION |
| Jun 1, 2021 | NIH | SBIR Phase I Magnetic sorting and selection of producer cells based on secretion and growth using nanovial technology | $236K | PARTILLION BIOSCIENCE CORPORATION |
| May 31, 2021 | NIH | SBIR Phase I Magnetic sorting and selection of producer cells based on secretion and growth using nanovial technology | $236K | PARTILLION BIOSCIENCE CORPORATION |
| May 1, 2021 | NIH | SBIR Phase I Nanovials for high-throughput analysis and selection of single cells based on secreted bio-products | $220K | PARTILLION BIOSCIENCE CORPORATION |
| Apr 28, 2021 | NIH | SBIR Phase I Nanovials for high-throughput analysis and selection of single cells based on secreted bio-products | $220K | PARTILLION BIOSCIENCE CORPORATION |
Peer ranks
Federal funding#101
Awards as PI#37
Patents#273
Companies
- PARTILLION BIOSCIENCE CORPORATIONLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.